Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative ...
As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...
Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...
Tahoe Therapeutics and Alloy Therapeutics announced today that they are forming a jointly seeded new company focused on ...
Roorkee: Researchers at Indian Institute of Technology Roorkee (IIT Roorkee) have developed a high-diversity antibody ...
A research team engineered a rigid, nanometer-scale protein module to address the challenge of measuring antibody flexibility ...
NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for ...
AbbVie and RemeGen are collaborating on RC148, a novel PD-1/VEGF-targeted bispecific antibody already being developed as a ...
US pharma major AbbVie and China’s RemeGen today announced an exclusive licensing agreement for the development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results